GPC-Rx

GPC-Rx is a biotechnology company based in Oxford, UK, specializing in the discovery of small molecule drugs targeting G protein-coupled receptors (GPCRs). Spun out from the University of Oxford and the University of Cambridge, the company leverages a proprietary platform to study GPCRs in their native membrane environments. This approach allows for the identification of novel binding sites and the development of highly selective therapeutics for targets that have historically been difficult to drug. GPC-Rx is currently focused on advancing its internal pipeline in the areas of oncology and inflammatory diseases. The company is backed by Oxford Science Enterprises and maintains strong academic ties to leading research institutions in the UK.